All posts by Jann Bellamy

Jann J. Bellamy is a Florida attorney and lives in Tallahassee. She is one of the founders and Board members of the Society for Science-Based Medicine (SfSBM) dedicated to providing accurate information about CAM and advocating for state and federal laws that incorporate a science-based standard for all health care practitioners. She tracks state and federal bills that would allow pseudoscience in health care for the SfSBM website.  Her posts are archived here.    

Author

  • Jann J. Bellamy is a Florida attorney and lives in Tallahassee. She is one of the founders and Board members of the Society for Science-Based Medicine (SfSBM) dedicated to providing accurate information about CAM and advocating for state and federal laws that incorporate a science-based standard for all health care practitioners. She tracks state and federal bills that would allow pseudoscience in health care for the SfSBM website. 

    Her posts are archived here.

     

     

Trump administration announces some COVID-19 tests can skip FDA review, providing new opportunities for dubious lab tests

The Trump administration unexpectedly announced that the FDA will no longer regulate some lab tests, including those for COVID-19. In addition to potentially allowing unreliable COVID tests on the market, the decision creates an opening for more bogus CAM tests.

/ August 27, 2020

Consumer groups urge feds to act against Mercola and his false COVID-19 claims

Consumer rights organizations urge the FDA and FTC to take action against Joseph Mercola and his businesses over their false, misleading, and dangerous claims that their products will prevent, treat or cure COVID-19.

/ August 13, 2020

Monsanto gets injunction against California’s mandated cancer warning for glyphosate

A federal district court permanently enjoined California from requiring a cancer warning for glyphosate on First Amendment grounds. The battle between the law and science continues.

/ July 30, 2020

Expert review warns against compounded bioidentical hormone therapies

A National Academies report finds widely-marketed compounded hormone replacement therapies lack evidence of safety and effectiveness, and recommends restriction of their use.

/ July 16, 2020

FTC settles false advertising suit against low-level light therapy marketer with $22 million judgment

Per a settlement with the FTC, the marketers of Willow Curve, a low-level light therapy device costing hundreds of dollars, will have to stop making deceptive claims that the device treats chronic, severe pain and associated inflammation. Any health claims made for the device must be supported by "competent and reliable scientific evidence".

/ July 2, 2020

FTC warns naturopaths, acupuncturists, physicians, and chiropractors about false and misleading COVID-19 claims  

Since March, the FTC has issued almost 250 warning letters to companies and individuals making unsubstantiated claims for COVID-19 treatments. Included among these are naturopaths, acupuncturists, physicians, and chiropractors.

/ June 18, 2020

Cell-cultured meat: Earth’s savior or just a $600 burger?

Cell-cultured meat raises may issues, including safety, environmental impact, cost, and our current technology's ability to manufacture it. Most importantly, when it finally hits the supermarket, will consumers buy it?

/ June 4, 2020

NewsGuard identifies social media “super-spreaders” of COVID-19 misinformation

NewsGuard has identified "super-spreaders" of COVID-19 misinformation on Facebook and Twitter, including Dr. Joseph Mercola, the NVIC, Rush Limbaugh, and Ty Bollinger.

/ May 21, 2020

Chinese government recommends bear bile for COVID-19

The Chinese Government is relentlessly promoting TCM for COVID-19, including a remedy containing bear bile, which is cruelly extracted from the gall bladders of living wild or "farmed" bears.

/ May 7, 2020

FDA issues new CBD safety warnings, calls for more research to guide regulation

The FDA recently warned the public about CBD health risks and urged further research. Meanwhile, special interest groups are pressing Congress and the FDA for quick action to allow CBD in dietary supplements and other consumer products.

/ April 23, 2020